The study particularly highlighted the inhibition of SRC, STAT3, PIK3CA, MAPK1, EGFR, and JAK1 through molecular docking, which are key proteins involved in the EGFR Tyrosine Kinase Inhibitor Resistance pathway in NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.